8,179 results match your criteria: "Atatuerk University Medical Faculty[Affiliation]"
Am J Cardiol
January 2025
Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota. Electronic address:
The impact of diabetes mellitus (DM) on the outcomes of bifurcation percutaneous coronary intervention (PCI) has received limited study. We compared the procedural characteristics and outcomes of patients with and without DM in 1,302 bifurcation PCIs (1,147 patients) performed at 5 centers between 2013 and 2024. The prevalence of DM was 33.
View Article and Find Full Text PDFCurr Oncol
October 2024
Division of Medical Oncology, Departmant of Internal Medicine, Ege University Medical Faculty, 35100 Izmir, Turkey.
Hyperprogressive disease (HPD) is described as the unexpected rapid growth of a tumour accompanied by a decline in performance status. While immune checkpoint inhibitors (ICIs) have improved outcomes in advanced melanoma, HPD remains a significant challenge in a subset of patients. Although HPD has been extensively studied in various solid tumours, research specifically focusing on advanced melanoma remains limited.
View Article and Find Full Text PDFInquiry
October 2024
Erciyes University Medical Faculty, Kayseri, Turkey.
J Voice
October 2024
Department of Anesthesiology, Acıbadem Kozyatağı Hospital, Ondokuz Mayıs Mah. Begol̥nya Sokak. No:12, Kadıköy/İstanbul, Türkiye. Electronic address:
Objective: The aim of this study was to measure laryngeal dimensions in a sample of Turkish cadavers, including males and females of various ages and heights.
Materials And Methods: Morphological measurement was performed on 102 laryngeal specimens. Hyoid bone and laryngeal cartilages were removed from human cadavers.
Seizure
December 2024
Medipol University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Neurology, Istanbul, Turkiye.
Objective: To evaluate the etiology-specific diagnosis of early-onset developmental epileptic encephalopathies (EO-DEEs) in a nationwide Turkish cohort to determine the implications for therapeutic management.
Methods: The cohort comprised 1450 patients who underwent EO-DEE. The utility of genetic testing was assessed with respect to the initial phases of next generation sequencing (NGS) (2005-2013) and the current NGS era (2014-2022).
Am J Clin Oncol
October 2024
Department of Radiation Oncology, Ankara University Medical Faculty, Ankara.
Objectives: The aim of this retrospective multicenter study was to evaluate the prognostic significance of low muscle mass, and inflammatory markers in patients with stage III nonsmall cell lung cancer (NSCLC) who received definitive chemoradiotherapy (CRT). Furthermore, the study aimed to determine the threshold value of disease-specific low muscle mass.
Methods: A total of 461 patients with stage III NSCLC were evaluated.
Int Arch Allergy Immunol
October 2024
Division of Pediatric Allergy and Immunology, School of Medicine, Marmara University, Istanbul, Turkey.
Introduction: Individuals with inborn errors of immunity (IEI) are at increased risk of respiratory infection and frequently receive prolonged broad-spectrum antibiotics, leading to antibiotic resistance. The aim of this study was to identify respiratory pathogens and antibiotic resistance patterns in IEI patients.
Methods: We retrospectively studied 36 IEI patients with positive bacterial growth in sputum cultures between 2014 and 2023.
Neurol India
September 2024
Department of Neurosurgery, Bahcesehir University Medical Faculty, Istanbul, Turkey.
Eur Arch Otorhinolaryngol
January 2025
Department of Otorhinolaryngology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Purpose: Reinke's edema is a benign lesion affecting the subepithelial layer of the vocal cords, often associated with moderate or heavy smoking. Smoking is the most significant risk factor for dysplastic laryngeal lesions, laryngeal carcinomas, and Reinke's edema. Thus, Reinke's edema could potentially be a predisposing factor for laryngeal malignancy in the long term.
View Article and Find Full Text PDFHeliyon
October 2024
Ankara University Medical Faculty, Department of Medical Oncology, Turkey.
Turk Kardiyol Dern Ars
October 2024
Department of Cardiology, Gazi University Medical Faculty, Ankara, Türkiye.
J Obstet Gynaecol
December 2024
Department of Internal Medicine, Cigdem Cindoglu Assoc/Prof, Harran University Medical Faculty, Sanliurfa, Turkey.
Background: Preeclampsia is still a disease whose cause and treatment have not been fully characterised. Early-onset preeclampsia occurs before the 34th week of pregnancy, and late-onset preeclampsia occurs at 34 weeks or older. In our study, we investigated whether the prognostic nutritional index (PNI) and pan immune inflammation value (PIV), which are used in the prognosis and prediction of diseases in new studies in the literature, are useful for predicting early-onset preeclampsia.
View Article and Find Full Text PDFActa Cardiol
October 2024
Department of Cardiology, Mardin Artuklu University Medical Faculty, Mardin, Turkey.
Background: Sarcopenia is a progressive age-related skeletal muscle disease associated with adverse outcomes in those with cardiovascular disease. In this study, the prevalence of sarcopenia and its effect on clinical outcomes in heart failure with mildly reduced ejection fraction (HFmrEF) patients were examined.
Methods: A total of 722 patients from three centres who applied to the outpatient clinic with the diagnosis of HFmrEF between 01 January 2020 and 01 June 2021 were included in the study retrospectively.
Behav Pharmacol
December 2024
Department of Medical Pharmacology, Akdeniz University Medical Faculty, Antalya, Turkey.
Akathisia is an underestimated but disturbing extrapyramidal side effect of antidepressants, which could reduce treatment compliance in mood disorders. This study aimed to investigate the frequency and risk factors in patients treated with selective serotonin reuptake inhibitors/serotonin and noradrenaline reuptake inhibitors (SSRI/SNRI). In addition, we assessed the impact of akathisia on the quality of life (QoL).
View Article and Find Full Text PDFInt Ophthalmol
October 2024
Department of Ophthalmology, Division of Cornea, Erciyes University Medical Faculty, Kayseri, Turkey.
J Med Educ Curric Dev
October 2024
CHU Mohammed VI de Marrakech HME, Marrakech, Morocco.
It is the year 2050, and the world of medicine has undergone significant changes. With the advent of advanced technology and medical breakthroughs, medical schools have become even more competitive. Medical students are now required to have an exceptional academic record, outstanding research experience, and a perfect social media presence.
View Article and Find Full Text PDFCancer Control
October 2024
Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey.
Background: To examine the prognostic relevance of pan-immune-inflammation value (PIV) in locally advanced nasopharyngeal carcinomas (LA-NPC) patients treated with concurrent chemoradiotherapy (CCRT) definitively.
Methods: We used receiver operating characteristic (ROC) curve analysis to determine an optimal PIV cutoff that could effectively divide the patient cohort into two distinct groups based on distant metastasis-free (DMFS) and overall survival (OS) results. For this purpose, receiver operating characteristic (ROC) curve analysis was employed.
Cytopathology
November 2024
The Fingerland Department of Pathology, Charles University Medical Faculty Hospital, Hradec Kralove, Czech Republic.
BMC Nephrol
October 2024
Department of Internal Medicine, Division of Nephrology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.
Background: We evaluated the efficacy of different immunosuppressive regimens in patients with primary membranous nephropathy in a large national cohort.
Methods: In this registry study, 558 patients from 47 centers who were treated with at least one immunosuppressive agent and had adequate follow-up data were included. Primary outcome was defined as complete (CR) or partial remission (PR).
World J Gastrointest Surg
September 2024
Department of General Surgery, Kahramanmaras Necip Fazıl City Hospital, Kahramanmaras 46140, Türkiye.
Pediatr Res
September 2024
Department of Respiratory and Infectious Medicine, Hannover Medical School, Hannover, Germany.
Background: Biliary atresia (BA) is a rare condition of unknown origin in newborns with jaundice. In BA bile ducts are non-functional, causing neonatal cholestasis and following liver fibrosis and failure.
Methods: This retrospective study included liver biopsies of 14 infants with BA aged [mean ± SD] 63 ± 23 days.
J Clin Med
September 2024
Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, 89075 Ulm, Baden-Wuerttemberg, Germany.
Children (Basel)
September 2024
Department of Orthopaedics and Traumatology, Kastamonu University Medical Faculty, 37100 Kastamonu, Turkey.
Objective: This study delves into the implications of adenoidectomy for scoliosis progression, investigating the intricate nexus of hypoxia, spinal curvature, and surgical intervention. With adenoidectomy being a common procedure for addressing pediatric sleep-disordered breathing, this research study explores its potential impact on spinal health.
Patients And Methods: Employing a retrospective cohort design, this study gathered data from patients who underwent adenoidectomy, including those with scoliosis, between January 2017 and March 2023.
Circulation
November 2024
M3C-Necker, Congenital and Paediatric Cardiology Department, Hospital Necker-Enfants Malades, University of Paris Cité, France (D.B.).
Background: Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is an established treatment for heart failure (HF) with reduced left ventricular ejection fraction. It has not been rigorously compared with angiotensin-converting enzyme inhibitors in children. PANORAMA-HF (Prospective Trial to Assess the Angiotensin Receptor Blocker Neprilysin Inhibitor LCZ696 Versus Angiotensin-Converting Enzyme Inhibitor for the Medical Treatment of Pediatric HF) is a randomized, double-blind trial that evaluated the pharmacokinetics and pharmacodynamics (PK/PD), safety, and efficacy of sacubitril/valsartan versus enalapril in children 1 month to <18 years of age with HF attributable to systemic left ventricular systolic dysfunction (LVSD).
View Article and Find Full Text PDF